UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________________ FORM 20-F ______________________________ o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR...
Preliminary Final Report including Appendix 4E
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
- Appendix 3Y - Philip Krause
- Notification regarding unquoted securities - MSB
- Mesoblast 2026 Full Year Financial Results Webcast
- Major Milestone Treatment Completed in P3 Trial for CLBP
- Becoming a substantial holder
Later from Mesoblast
- Annual Financial Results Presentation
- MSB Annual Financial Results and Operational Update
- Mesoblast Reports Substantial Revenue Growth to US$120M
- Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)
- Ceasing to be a substantial holder
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast